[October 24, 2009] www.Xtremepicks.Com: Xtremepicks Alerts October 23, 2009 : IMMU, ANCI, SLTC and PCLN Tweet (M2 PressWIRE Via Acquire Media NewsEdge) Xtremepicks.com Alerts include Immunomedics, Inc. (Nasdaq: IMMU), American CareSource Holdings (NASDAQ: ANCI), Selectica (NASDAQ: SLTC) and Priceline.com(R) (NASDAQ: PCLN) Immunomedics, Inc. (Nasdaq:IMMU) trading at $3.93 per share on trading volume of 309,010 shares. In a press release out on October 23, Immunomedics Receives Corporate Award From New Jersey Inventors Hall of Fame MORRIS PLAINS, N.J., Oct 23, 2009 -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that the Company received a Corporate Award from the New Jersey Inventors Hall of Fame (NJIHoF) in recognition of the Company's significant achievements related to the development of monoclonal antibodies. About Immunomedics Immunomedics is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, we have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. We also have a majority ownership in IBC Pharmaceuticals, Inc., which is developing a novel Dock-and-Lock (DNL) methodology with us for making fusion proteins and multifunctional antibodies, and a new method of delivering imaging and therapeutic agents selectively to disease, especially different solid cancers (colorectal, lung, pancreas, etc.), by proprietary, antibody-based, pretargeting methods. We believe that our portfolio of intellectual property, which includes approximately 139 patents issued in the United States and more than 300 other patents issued worldwide, protects our product candidates and technologies. For additional information on us, please visit our website at www.immunomedics.com. The information on our website does not, however, form a part of this press release. American CareSource Holdings (NASDAQ: ANCI) trading at $2.63 per share on trading volume of 336,674 shares. In a press release out on October 23, American CareSource Announces Date of Third Quarter Results and Conference Call DALLAS, Oct 23, 2009 -- American CareSource Holdings (NASDAQ: ANCI) today announced that it will release its financial results for the third quarter ended September 30, 2009, after the close of U.S. financial markets on Monday, November 9, 2009. An accompanying conference call to discuss the results will be held at 8:30 a.m. ET, on Tuesday, November 10, 2009. About American CareSource Holdings, Inc. American CareSource Holdings, the first national, publicly traded ancillary care network services company, offers a comprehensive national network of over 4,000 ancillary service providers at more than 30,000 sites through its subsidiary, Ancillary Care Services. Ancillary Care Services provides ancillary health care services through its network that offers cost effective alternatives to physician and hospital-based services. This market is estimated at $574 billion and has grown to 30% of total national health expenditures. These providers offer services in 31 categories including laboratories, dialysis centers, free-standing diagnostic imaging centers, non-hospital surgery centers, as well as durable medical equipment such as orthotics and prosthetics and others. The Company's ancillary network and management provides a complete outsourced solution for a wide variety of health care payors and plan sponsors including self-insured employers, indemnity insurers, PPOs, HMOs, third party administrators and both federal and local governments. For additional information, please visit www.anci-care.com. Selectica (NASDAQ:SLTC) trading at $0.32 per share on trading volume of 15,882 shares. In a press release out on October 23, Selectica to Announce Second Quarter Fiscal 2010 Financial Results on October 29, 2009 SAN JOSE, Calif., Oct 23, 2009 -- Selectica (NASDAQ:SLTC), a leading provider of contract lifecycle management and sales configuration solutions, will report financial results for its second quarter fiscal 2010 after the close of the market on Thursday, October 29, 2009. Selectica will host a conference call to discuss its financial results and operational highlights at 5:00 p.m. EDT (2:00 p.m. PDT) on the same day. About Selectica, Inc. Selectica (NASDAQ:SLTC) provides Global 2000 companies with solutions that automate complex contract management and sales configuration processes. Selectica's enterprise solutions streamline critical business functions including sales, procurement, and corporate governance, and enable companies to eliminate risk, increase revenue, and cut costs. Selectica customers represent leaders in manufacturing, technology, retail, healthcare, and telecommunications, including Bell Canada, Cisco, Covad Communications, Fujitsu, Hitachi, International Paper, ManTech, Levi Strauss & Co., Qwest Communications, and Rockwell Automation. For more information, visit www.selectica.com. Priceline.com(R) (NASDAQ: PCLN) trading at $177.72 per share on trading volume of 384,168 shares. In a press release out on October 23, Priceline.com(R) Added to NASDAQ-100 Index NORWALK, Conn., Oct 23, 2009 -- Priceline.com(R) (NASDAQ: PCLN) announced today that it will be added to the NASDAQ-100 Index(R), effective at the start of trading Thursday, October 29, 2009. About Priceline.com(R) Incorporated Priceline.com Incorporated (Nasdaq: PCLN) www.priceline.com provides online travel services in 29 languages in over 78 countries in Europe, North America, Asia, the Middle East and Africa. Included in the priceline.com family of companies is Booking.com, a leading international online hotel reservation service, priceline.com, a leading U.S. online travel service for value-conscious leisure travelers, and Agoda.com, an Asian online hotel reservation service. Priceline.com believes that Booking.com is Europe's largest and fastest growing hotel reservation service, with a network of affiliated Web sites. Booking.com operates in over 70 countries in 24 languages and offers its customers access to over 71,000 participating hotels worldwide. Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience. Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at [email protected] Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS [ Back To TMCnet.com's Homepage ]